Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

DR. KARELYS RIVERA AND ASSOCIATES

NPI: 1467841668 · EDINBURG, TX 78539 · Pediatrics Physician · NPI assigned 01/12/2015

$1.41M
Total Medicaid Paid
58,988
Total Claims
49,326
Beneficiaries
40
Codes Billed
2018-12
First Month
2024-12
Last Month

Provider Details

Authorized OfficialRIVERA, KARELYS (OWNER)
NPI Enumeration Date01/12/2015

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 18 $912.40
2020 1,476 $32K
2021 12,888 $296K
2022 16,608 $380K
2023 16,068 $387K
2024 11,930 $311K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 6,599 5,819 $338K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8,639 7,446 $315K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1,940 1,923 $151K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1,307 1,304 $108K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1,417 1,355 $107K
90460 Immunization administration through 18 years of age via any route, first or only component 7,224 3,394 $78K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4,330 2,071 $57K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 6,754 6,266 $42K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,839 2,719 $38K
96110 Developmental screening, with scoring and documentation, per standardized instrument 4,517 4,320 $32K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 347 345 $31K
92588 1,500 1,490 $26K
99429 699 689 $23K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,680 1,370 $19K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 268 258 $11K
87807 860 813 $9K
90461 1,458 1,284 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 217 216 $5K
83655 284 275 $3K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 20 19 $1K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 12 12 $1K
99000 69 64 $745.20
81002 219 199 $618.84
J0696 Injection, ceftriaxone sodium, per 250 mg 505 462 $489.12
J1100 Injection, dexamethasone sodium phosphate, 1 mg 885 839 $358.71
90680 691 689 $0.00
90698 882 880 $0.00
90744 333 330 $0.00
90686 837 835 $0.00
90677 266 264 $0.00
90651 38 38 $0.00
90716 27 27 $0.00
90696 13 13 $0.00
90619 12 12 $0.00
90633 378 370 $0.00
90670 846 840 $0.00
90700 24 24 $0.00
90707 27 27 $0.00
90710 13 13 $0.00
90734 12 12 $0.00